1. Home
  2. CATX

CATX

Perspective Therapeutics Inc.

Logo Perspective Therapeutics Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Founded: 1983 Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 892.1M IPO Year: N/A
Target Price: $1.53 AVG Volume (30 days): 3.9M
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.17 EPS Growth: N/A
52 Week Low/High: $0.21 - $1.60 Next Earning Date: 05-13-2024
Revenue: $1,434,000 Revenue Growth: N/A
Revenue Growth (this year): -64.44% Revenue Growth (next year): 766.67%

Share on Social Networks: